Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis
- aDepartment of Dynamic Pathology, bDepartment of Neurology, cFirst Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan, dDivision of Internal Medicine, Sonobe Tan-ikai Hospital, Kyoto, Japan
- Dr Shinji Fushiki, Department of Dynamic Pathology, Research Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602–8566, Japan. Telephone 0081 75 251 5769; fax 0081 75 251 5849; email:sfushiki{at}koto.kpu-m.ac.jp
- Received 8 February 1999
- Revised 17 May 1999
- Accepted 28 May 1999
Abstract
OBJECTIVES A Japanese family with cerebrotendinous xanthomatosis (CTX) was investigated for a sequence alteration in the sterol 27-hydroxylase gene (CYP27). The expression ofCYP27 has been mostly explored using cultured fibroblasts, prompting the examination of the transcripts from blood leucocytes as a simple and rapid technique.
METHODS An alteration in CYP27 of the proband was searched for by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis and subsequent sequencing. Samples of RNA were subjected to reverse transcription PCR (RT-PCR) and the product of the proband was amplified with nested primers and sequenced.
RESULTS A homozygous G to A transition at the 5′ end of intron 7 was detected in the patient. In RT-PCR analysis, only a truncated transcript was detected in the patient, whereas both normal and truncated transcripts were detected in the siblings. The sequencing of the patient’s cDNA fragment disclosed a direct conjuction of exon 6 and exon 8.
CONCLUSION The mutation at splice donor site and the truncation of mRNA were identical with those of a recently reported Italian patient, although different in symptomatology. The application of blood leucocytes can be a simple technique on analysing a constructive abnormality ofCYP27 mRNA.
